Nicolas Scheyer, MD – FDA Inspection, Nov 21, 2024

Record Details

This FDA Inspection record concerns Nicolas Scheyer, MD, with an inspection on November 21, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Nicolas Scheyer, MD
Inspection Date: November 21, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations
People: Tawny L. Colling (Company Rep)
Theressa B. Smith (Issuing Officer)

View Company Profile

ID · 1809285b-38e2-4c1c-a366-1d4bb7b45d0c

Inspection Facts

Inspection number: 1256486
FDA center: Human Drugs

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nicolas Scheyer, MD

FDA Inspection

Nicolas Scheyer, MDNovember 21, 2024

Nicolas Scheyer, MD – FDA Inspection, Nov 21, 2024

Record Details

This FDA Inspection record concerns Nicolas Scheyer, MD, with an inspection on November 21, 2024, issued by the Office of Inspections and Investigations, covering human drugs.